Literature DB >> 26101343

Exacerbating Pressure Overload-Induced Cardiac Hypertrophy: Novel Role of Adaptor Molecule Src Homology 2-B3.

Xuehai Zhu1, Jing Fang1, Ding-Sheng Jiang1, Peng Zhang1, Guang-Nian Zhao1, Xueyong Zhu1, Ling Yang1, Xiang Wei2, Hongliang Li2.   

Abstract

The adaptor protein Src homology 2-B3 (SH2B3), which belongs to a subfamily of Src homology 2 proteins, is a broad inhibitor of growth factors and cytokine signaling in hematopoietic cells. However, the role of SH2B3 in nonhematopoietic systems, particularly cardiomyocytes, has not been defined. In this study, we observed noticeable increase in SH2B3 protein expression during pathological cardiac remodeling in both humans and rodents. Follow-up in vitro gain- and loss-of-function studies suggested that SH2B3 promotes the cardiomyocyte hypertrophy response. Consistent with the cell phenotype, SH2B3 knockout (SH2B3(-/-)) mice exhibited attenuated cardiac remodeling with preserved cardiac function after chronic pressure overload. Conversely, cardiac-specific SH2B3 overexpression aggravated pressure overload-triggered cardiac hypertrophy, fibrosis, and dysfunction. Mechanistically, SH2B3 accelerates and exacerbates cardiac remodeling through the activation of focal adhesion kinase, which, in turn, activates the prohypertrophic downstream phosphoinositide 3-kinase-AKT-mammalian target of rapamycin/glycogen synthase kinase 3β signaling pathway. Finally, we generated a novel SH2B3 knockout rat line and further confirmed the protective effects of SH2B3 deficiency on cardiac remodeling across species. Collectively, our data indicate that SH2B3 functions as a novel and effective modulator of cardiac remodeling and failure.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  LNK protein, mouse; TALEN; aortic banding; cardiomegaly; knockout rats

Mesh:

Substances:

Year:  2015        PMID: 26101343     DOI: 10.1161/HYPERTENSIONAHA.115.05183

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  13 in total

Review 1.  Genome editing in cardiovascular diseases.

Authors:  Alanna Strong; Kiran Musunuru
Journal:  Nat Rev Cardiol       Date:  2016-09-09       Impact factor: 32.419

Review 2.  Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing.

Authors:  Alexandra C Chadwick; Kiran Musunuru
Journal:  Curr Atheroscler Rep       Date:  2017-07       Impact factor: 5.113

Review 3.  Genome Editing for the Study of Cardiovascular Diseases.

Authors:  Alexandra C Chadwick; Kiran Musunuru
Journal:  Curr Cardiol Rep       Date:  2017-03       Impact factor: 2.931

Review 4.  Role of the microRNA-29 family in myocardial fibrosis.

Authors:  Changyan Li; Nan Wang; Peng Rao; Limeiting Wang; Di Lu; Lin Sun
Journal:  J Physiol Biochem       Date:  2021-05-28       Impact factor: 4.158

5.  Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy.

Authors:  Ke-Qiong Deng; Aibing Wang; Yan-Xiao Ji; Xiao-Jing Zhang; Jing Fang; Yan Zhang; Peng Zhang; Xi Jiang; Lu Gao; Xue-Yong Zhu; Yichao Zhao; Lingchen Gao; Qinglin Yang; Xue-Hai Zhu; Xiang Wei; Jun Pu; Hongliang Li
Journal:  Nat Commun       Date:  2016-06-01       Impact factor: 14.919

Review 6.  Noninvasive Positive Pressure Ventilation in Chronic Heart Failure.

Authors:  Hao Jiang; Yi Han; Chenqi Xu; Jun Pu; Ben He
Journal:  Can Respir J       Date:  2016-11-06       Impact factor: 2.409

Review 7.  From engineering to editing the rat genome.

Authors:  Stephen Meek; Tomoji Mashimo; Tom Burdon
Journal:  Mamm Genome       Date:  2017-07-27       Impact factor: 2.957

8.  C-C Motif Chemokine Receptor 9 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction.

Authors:  Zhengxi Xu; Fanghua Mei; Hanning Liu; Cheng Sun; Zhe Zheng
Journal:  J Am Heart Assoc       Date:  2016-05-04       Impact factor: 5.501

9.  Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure.

Authors:  Ane M Salvador; Tania Nevers; Francisco Velázquez; Mark Aronovitz; Bonnie Wang; Ana Abadía Molina; Iris Z Jaffe; Richard H Karas; Robert M Blanton; Pilar Alcaide
Journal:  J Am Heart Assoc       Date:  2016-03-15       Impact factor: 5.501

10.  Translocase of Inner Membrane 50 Functions as a Novel Protective Regulator of Pathological Cardiac Hypertrophy.

Authors:  Kai Tang; Yifan Zhao; Hailing Li; Mengyun Zhu; Weiming Li; Weijing Liu; Guofu Zhu; Dachun Xu; Wenhui Peng; Ya-Wei Xu
Journal:  J Am Heart Assoc       Date:  2017-04-21       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.